Save
Share
Reply to: Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patient.
Journal:
Anti-Cancer Drugs
Published:
May 09, 2025
Authors
Daniele Cattaneo
,
Alessandra Iurlo
Relevant Conditions
Chronic Myelogenous Leukemia (CML)
,
Leukemia
View Article From Source
Similar Publications
We couldn’t find any related articles. Please check for more on the main search page.